Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
VERI
|
G Louis Graziadio Iii
Director |
SELL
Open market or private sale
|
Direct | 982 Reduced 0.73% |
$35,745
$36.4 p/Share
|
Jan 08
2021 |
VERI
|
G Louis Graziadio Iii
Director |
SELL
Open market or private sale
|
Indirect | 13,653 Reduced 5.98% |
$496,969
$36.4 p/Share
|
Jan 08
2021 |
FINS
|
Angel Oak Capital Advisors, LLC |
SELL
Open market or private sale
|
Direct | 35 Reduced 100.0% |
$562
$16.07 p/Share
|
Jan 08
2021 |
AKTS
|
Arthur Geiss |
SELL
Open market or private sale
|
Direct | 2,498 Reduced 2.17% |
$34,972
$14.0 p/Share
|
Jan 08
2021 |
GAN
|
Jeffrey Bruce Berman
EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 349 Reduced 100.0% |
$7,901
$22.64 p/Share
|
Jan 08
2021 |
MMNFF
|
Wicklow Capital Inc.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 1,244,806 Reduced 4.88% |
$248,961
$0.2 p/Share
|
Jan 08
2021 |
DYFN
|
Angel Oak Capital Advisors, LLC |
SELL
Open market or private sale
|
Direct | 31 Reduced 100.0% |
$551
$17.77 p/Share
|
Jan 08
2021 |
CABA
|
5 Am Ventures V, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 302,000 Reduced 8.96% |
$3,926,000
$13.0 p/Share
|
Jan 08
2021 |
TCRT
|
Jill Buck
EVP, GM Gene Therapy |
SELL
Open market or private sale
|
Direct | 27,894 Reduced 12.27% |
$87,029
$3.12 p/Share
|
Jan 08
2021 |
TCRT
|
Kevin G Lafond
SVP, Treasurer & CAO |
SELL
Open market or private sale
|
Direct | 18,020 Reduced 21.98% |
$55,682
$3.09 p/Share
|
Jan 08
2021 |
TCRT
|
Robert Hadfield
Chief Legal Officer and Sec. |
SELL
Open market or private sale
|
Direct | 26,500 Reduced 16.58% |
$82,680
$3.12 p/Share
|
Jan 08
2021 |
BLFS
|
Marcus Schulz
Chief Revenue Officer |
SELL
Open market or private sale
|
Direct | 293 Reduced 0.74% |
$11,430
$39.01 p/Share
|
Jan 08
2021 |
ATAO
|
Erop Capital LLC |
SELL
Open market or private sale
|
Direct | 129,000 Reduced 0.26% |
$32,250
$0.25 p/Share
|
Jan 08
2021 |
DUSYF
|
Allen Wai Hong Chee
Director |
BUY
Open market or private purchase
|
Direct | 1,100 Added 0.11% |
$1,331
$1.21 p/Share
|
Jan 08
2021 |
CBDS
|
David Tobias
CEO |
SELL
Open market or private sale
|
Direct | 51,652 Reduced 1.54% |
$31,508
$0.61 p/Share
|
Jan 08
2021 |
GCMG
|
Adage Capital Partners Gp, L.L.C.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 2,913 Added 0.05% |
$37,898
$13.01 p/Share
|
Jan 07
2021 |
PLXS
|
Dean A Foate
Director |
SELL
Open market or private sale
|
Indirect | 4,000 Reduced 100.0% |
$342,000
$85.5 p/Share
|
Jan 07
2021 |
PINS
|
Benjamin Silbermann
Director |
SELL
Open market or private sale
|
Direct | 105,000 Reduced 100.0% |
$7,313,250
$69.65 p/Share
|
Jan 07
2021 |
NVAX
|
John Trizzino
President and COO |
SELL
Open market or private sale
|
Direct | 506 Reduced 63.81% |
$62,830
$124.17 p/Share
|
Jan 07
2021 |
PFSI
|
Stanford L Kurland
Director |
SELL
Open market or private sale
|
Indirect | 1,000 Reduced 0.01% |
$58,750
$58.75 p/Share
|
Jan 07
2021 |
MNTV
|
Thomas E Hale
President |
SELL
Open market or private sale
|
Direct | 4,300 Reduced 1.17% |
$116,100
$27.0 p/Share
|
Jan 07
2021 |
GNK
|
Ccp Ii Cayman Gp Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 125,000 Reduced 2.57% |
$1,038,750
$8.31 p/Share
|
Jan 07
2021 |
GNK
|
Centerbridge Credit Partners, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 125,000 Reduced 2.57% |
$1,038,750
$8.31 p/Share
|
Jan 07
2021 |
BAND
|
David A. Morken
Chairman & CEO |
SELL
Open market or private sale
|
Direct | 31,740 Reduced 97.46% |
$4,760,365
$149.98 p/Share
|
Jan 07
2021 |
ABML
|
Douglas Cole
Director |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 0.12% |
$22,600
$1.13 p/Share
|
Jan 07
2021 |
EVER
|
John Brandon Wagner
CFO and Treasurer |
SELL
Open market or private sale
|
Direct | 3,800 Reduced 1.84% |
$148,010
$38.95 p/Share
|
Jan 07
2021 |
ADPT
|
Julie Rubinstein
President and COO |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 100.0% |
$859,500
$57.3 p/Share
|
Jan 07
2021 |
CRM
|
Srinivas Tallapragada
Chief Eng/Cust Success Officer |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 9.84% |
$1,082,500
$216.5 p/Share
|
Jan 07
2021 |
SCHW
|
Jonathan M. Craig
MD, Head of Investor Services |
SELL
Open market or private sale
|
Indirect | 3,503 Reduced 100.0% |
$206,607
$58.98 p/Share
|
Jan 07
2021 |
DE
|
Marc A Howze
Group Pres., Life Sol & CAO |
SELL
Open market or private sale
|
Direct | 8,585 Reduced 28.73% |
$2,566,915
$299.0 p/Share
|
Jan 07
2021 |
BRKR
|
Marc A Kastner |
SELL
Open market or private sale
|
Direct | 1,236 Reduced 9.98% |
$69,908
$56.56 p/Share
|
Jan 07
2021 |
BWXT
|
David S Black
Sr. V.P., CFO |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 1.42% |
$59,080
$59.08 p/Share
|
Jan 07
2021 |
NEOG
|
Steven J. Quinlan
VP & CFO |
SELL
Open market or private sale
|
Direct | 9,333 Reduced 40.93% |
$788,545
$84.49 p/Share
|
Jan 07
2021 |
CDLX
|
Kirk Somers
Chief Legal & Privacy Officer |
SELL
Open market or private sale
|
Direct | 983 Reduced 1.62% |
$132,784
$135.08 p/Share
|
Jan 07
2021 |
BLFS
|
Walter Villiger
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 30,000 Reduced 0.82% |
$1,186,500
$39.55 p/Share
|
Jan 07
2021 |
BUDZ
|
Nicole M Breen
Secretary/Treasurer |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 0.05% |
$2,400
$0.24 p/Share
|
Jan 07
2021 |
MRNA
|
Stephane Bancel
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 0.13% |
$1,200,000
$120.0 p/Share
|
Jan 07
2021 |
PCVX
|
Robert Lorne Hopfner
Director |
SELL
Open market or private sale
|
Indirect | 47,580 Reduced 0.74% |
$1,365,070
$28.69 p/Share
|
Jan 07
2021 |
LUMO
|
James E Flynn
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 16,172 Reduced 0.89% |
$399,448
$24.7 p/Share
|
Jan 07
2021 |
RPLA
|
Glazer Capital, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 100,000 Reduced 2.6% |
$1,038,000
$10.38 p/Share
|
Jan 07
2021 |
SCPE
|
Glazer Capital, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 246 Reduced 0.01% |
$2,583
$10.5 p/Share
|
Jan 07
2021 |
CRC
|
Goldentree Asset Management LP
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 14,500 Reduced 0.08% |
$363,370
$25.06 p/Share
|
Jan 07
2021 |
DELL
|
Jeffrey W Clarke
COO & Vice Chairman |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 20.64% |
$7,594,000
$75.94 p/Share
|
Jan 07
2021 |
ANET
|
Jayshree Ullal
CEO and Chairperson |
SELL
Open market or private sale
|
Indirect | 785 Reduced 0.03% |
$230,539
$293.68 p/Share
|
Jan 07
2021 |
ANET
|
Jayshree Ullal
CEO and Chairperson |
SELL
Open market or private sale
|
Indirect | 785 Reduced 0.03% |
$230,539
$293.68 p/Share
|
Jan 07
2021 |
ANET
|
Jayshree Ullal
CEO and Chairperson |
SELL
Open market or private sale
|
Direct | 1,273 Reduced 7.62% |
$373,855
$293.68 p/Share
|
Jan 07
2021 |
IBKR
|
Thomas Peterffy
Chairman |
SELL
Open market or private sale
|
Direct | 14,400 Reduced 0.15% |
$994,896
$69.09 p/Share
|
Jan 07
2021 |
TW
|
Enrico Bruni
MD, Co-Head of Global Markets |
SELL
Open market or private sale
|
Direct | 101,966 Reduced 49.92% |
$6,696,107
$65.67 p/Share
|
Jan 07
2021 |
DECK
|
David Powers |
SELL
Open market or private sale
|
Direct | 5,674 Reduced 6.67% |
$1,787,310
$315.0 p/Share
|
Jan 07
2021 |
LFUS
|
Gordon Hunter |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 17.73% |
$1,325,000
$265.0 p/Share
|
Jan 07
2021 |